Interaction between replication forks and topoisomerase I-DNA cleavable complexes: studies in a cell-free SV40 DNA replication system.

The extreme S-phase-specific cytotoxicity of camptothecin has been shown to involve active DNA replication. To investigate the role of DNA replication in camptothecin cytotoxicity, we have studied the interaction between the DNA replication machinery and the topoisomerase I-camptothecin-DNA ternary cleavable complex in a cell-free SV40 DNA replication system. The formation of topoisomerase I-camptothecin-DNA-cleavable complexes on the replication template efficiently and irreversibly inhibited DNA replication. Two aberrant forms of replication products were produced whose abundance varied with the concentrations of exogenously added topoisomerase I and camptothecin. At low concentrations of topoisomerase I and camptothecin, the major aberrant DNA replication product was close-to-unit-length-linear DNA, while at higher concentrations the predominant product was close-to-dimer-size-linear DNA. Analysis of these aberrant replication products has suggested a "collision" model in which the interaction between an advancing replication fork and a topoisomerase I-camptothecin-DNA-cleavable complex results in irreversible arrest of the replication fork and the formation of a double-strand DNA break at the fork. Concomitant with fork arrest and fork breakage, the reversible cleavable complex was converted into a topoisomerase I-linked DNA break. We propose that one or several of these events triggers S-phase-specific cell killing and G2-phase cell cycle arrest.

[1]  L. Liu,et al.  The involvement of active DNA synthesis in camptothecin-induced G2 arrest: altered regulation of p34cdc2/cyclin B. , 1992, Cancer research.

[2]  C. Cabañas,et al.  Camptothecin induces differentiation and stimulates the expression of differentiation-related genes in U-937 human promonocytic leukemia cells. , 1992, Cancer research.

[3]  J. Workman,et al.  Regulation of DNA replication in vitro by the transcriptional activation domain of GAL4-VP16. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[4]  B. Giovanella,et al.  Complete growth inhibition of human cancer xenografts in nude mice by treatment with 20-(S)-camptothecin. , 1991, Cancer research.

[5]  L. Liu,et al.  Involvement of nucleic acid synthesis in cell killing mechanisms of topoisomerase poisons. , 1990, Cancer research.

[6]  K. Lund,et al.  Minimal DNA duplex requirements for topoisomerase I-mediated cleavage in vitro. , 1990, The Journal of biological chemistry.

[7]  R. Snapka,et al.  Exposure to camptothecin breaks leading and lagging strand simian virus 40 DNA replication forks. , 1990, Biochemical and biophysical research communications.

[8]  K. Nakaya,et al.  Induction of differentiation of human and mouse myeloid leukemia cells by camptothecin. , 1990, Biochemical and biophysical research communications.

[9]  L. Liu,et al.  A model for tumor cell killing by topoisomerase poisons. , 1990, Cancer cells.

[10]  L. Liu,et al.  DNA topoisomerase I--targeted chemotherapy of human colon cancer in xenografts. , 1989, Science.

[11]  Y. Pommier,et al.  Differential requirement of DNA replication for the cytotoxicity of DNA topoisomerase I and II inhibitors in Chinese hamster DC3F cells. , 1989, Cancer research.

[12]  L. Liu,et al.  Arrest of replication forks by drug-stabilized topoisomerase I-DNA cleavable complexes as a mechanism of cell killing by camptothecin. , 1989, Cancer research.

[13]  L. Liu,et al.  Evidence for the reversibility of cellular DNA lesion induced by mammalian topoisomerase II poisons. , 1989, The Journal of biological chemistry.

[14]  R. Hertzberg,et al.  On the mechanism of topoisomerase I inhibition by camptothecin: evidence for binding to an enzyme-DNA complex. , 1989, Biochemistry.

[15]  J. Champoux,et al.  Mapping in vivo topoisomerase I sites on simian virus 40 DNA: asymmetric distribution of sites on replicating molecules , 1989, Molecular and cellular biology.

[16]  R. Sternglanz,et al.  Evidence that DNA topoisomerase I is necessary for the cytotoxic effects of camptothecin. , 1988, Molecular pharmacology.

[17]  J. Champoux.  Topoisomerase I is preferentially associated with isolated replicating simian virus 40 molecules after treatment of infected cells with camptothecin , 1988, Journal of virology.

[18]  J. Wang,et al.  DNA topoisomerase-targeting antitumor drugs can be studied in yeast. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[19]  R. Knippers,et al.  Camptothecin, a specific inhibitor of type I DNA topoisomerase, induces DNA breakage at replication forks , 1988, Molecular and cellular biology.

[20]  L. Liu,et al.  Proliferation-dependent regulation of DNA topoisomerase II in cultured human cells. , 1988, Cancer research.

[21]  L. Liu,et al.  Identification of mammalian DNA topoisomerase I as an intracellular target of the anticancer drug camptothecin. , 1988, Cancer research.

[22]  R. Hertzberg,et al.  Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I. , 1985, The Journal of biological chemistry.

[23]  J. Li,et al.  Simian virus 40 DNA replication in vitro. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[24]  R. Burgess,et al.  Nucleotide sequence preference at rat liver and wheat germ type 1 DNA topoisomerase breakage sites in duplex SV40 DNA. , 1984, Nucleic acids research.

[25]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[26]  L. Liu,et al.  Eukaryotic DNA topoisomerases: two forms of type I DNA topoisomerases from HeLa cell nuclei. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[27]  M. Horwitz,et al.  Effects of camptothecin on the breakage and repair of DNA during the cell cycle. , 1973, Cancer research.

[28]  R. Tobey.  Effects of cytosine arabinoside, daunomycin, mithramycin, azacytidine, adriamycin, and camptothecin on mammalian cell cycle traverse. , 1972, Cancer research.

[29]  L. Li,et al.  Action of camptothecin on mammalian cells in culture. , 1972, Cancer research.

[30]  R. Adamson,et al.  Studies on the antitumor activity, mechanism of action, and cell cycle effects of camptothecin. , 1971, Journal of the National Cancer Institute.